?

Thornberry Nancy

Director
Vertex Pharmaceuticals Incorporated
US, Boston [HQ]
CIK 1797826

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
1,637
Price per Share :
$418.27
Equivalence :
$684,707.99

Transaction History

  • A
    Form 4
    1,637 Shares After Transaction
    Value : $n/a
    $0.0
    05/01/24
  • Footnotes:
    #1 Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.